alantolactone has been researched along with Tongue Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukumoto, M; Hagiwara, S; Hikasa, H; Honma, T; Kondoh, Y; Maehama, T; Mak, TW; Nakatani, K; Nishina, H; Nishio, M; Osada, H; Otani, J; Suzuki, A; Yamaguchi, K; Yoshida, M | 1 |
1 other study(ies) available for alantolactone and Tongue Neoplasms
| Article | Year |
|---|---|
Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation.
Topics: Acyltransferases; Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents, Phytogenic; Auranofin; Biological Products; Cell Movement; Cell Nucleus; Cell Proliferation; Cell Self Renewal; DNA-Binding Proteins; Drug Discovery; Female; Inula; Lactones; Luciferases; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Nuclear Proteins; Phosphorylation; Proteolysis; Reactive Oxygen Species; Sesquiterpenes, Eudesmane; Small Molecule Libraries; TEA Domain Transcription Factors; Tongue Neoplasms; Transcription Factors; Transcriptional Activation; YAP-Signaling Proteins | 2021 |